SM2 The Consequences of Greater Net Price Transparency for Innovative Medicines in Europe: Insights from a Multi-Agent Simulation Model
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.1211
https://www.valueinhealthjournal.com/article/S1098-3015(21)01428-5/fulltext
Section Title :
Section Order :
10700
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01428-5&doi=10.1016/j.jval.2021.04.1211